Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Biochemical Engineering>Nucleoside drugs>DMT-2'-F-iBu-dG
DMT-2'-F-iBu-dG
  • DMT-2'-F-iBu-dG

DMT-2'-F-iBu-dG

Price Get Latest Price
Package 1kg 10kg 25kg
Min. Order: 1kg
Supply Ability: 500kg per month
Update Time: 2023-04-04

Product Details

Product Name: DMT-2'-F-iBu-dG CAS No.: 144089-96-3
Min. Order: 1kg Purity: 98%
Supply Ability: 500kg per month Release date: 2023/04/04


Zhejiang Hengkang Pharmaceutical Co. Ltd, is an emerging and fast-developing company, was established in 2004. Pharmaceutical Division is specialized in active pharmaceutical ingredients development, GMP manufacturing and marketing, and it provides the most innovative intermediates and APIs to world-wide customers.

Hengkang has 2 manufacturing plants: one is located in Fengkeng industrial zone with a total area of 69000 m2; the other one is located in coastal industrial zone with a total area of 70000 m2. The company has international standard facilities for API manufacturing and a professional team with cutting-edge technology, and provides the most innovative intermediates and active pharmaceutical ingredients to world-wide customers. Hengkang obtained: Drug Production License in 2006, GMP Certificate for Amiodarone Hydrochloride in October 2008, the Japanese Accreditation Certificate of Foreign manufacturer in December 2008, and the accreditation for High and New Technology Enterprise in 2017.

Hengkang stie was approved by EDQM, PMDA, KFDA, NMPA etc.



The patented product can only be used for scientific research and experiment, or be used with the permission of the patentee or its authorized licensor.










Company Profile Introduction

Hengkang Pharmaceutical was established in 2004, is specialized in active pharmaceutical ingredients development, GMP manufacturing and marketing,and provides the most innovative intermediates and APIs to world-wide customers. Nucleic Acid Division is lead by PhD team with rich pharmaceutical industry background, focusing on the independent research and development of key raw materials and excipients of mRNA drugs and oligos, such as Cap Analog and intermediate, Nucleotide, modified Nucleotide, Enzyme, Cationic acid(Ionizable Lipid), phosphoramidite, and commercial production base with GMP system. Dedicated to become the best partner of innovative nucleic acid drug field. The company has more than 6,000 square meters of R & D laboratories, more than 60,000 square meters of commercial GMP production base, first-class inspection instruments and production equipment; has a stable and experienced R & D team, as well as a perfect GMP production system, assists domestic and foreign mRNA R & D enterprises and manufacturers, and provides key raw materials and CMC solutions with controllable costs.? Can provide nucleotides and modified nucleotides, the product quality has reached the international level, and the cost is controllable, and the batch-to-batch quality is stable; Can provide capping materials for mRNA synthesis to achieve efficient and economical co-transcription capping; Can provide LNP raw materials that meet the requirements of the nucleic acid delivery system and meet the GMP production conditions; Can provide mRNA engineering enzymes and adopt absolute quantitative detection methods to ensure that key quality indicators such as enzyme bioactivity and residues are effectively controlled.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/100mg
Hefei Huana Biomedical Technology Co.,Ltd.
2023-03-09
$1.00/1kg
Yunbio Tech Co.,Ltd.
2023-08-07
$0.00/1KG
VIP3Y
Shanghai Qyubiotech Co., Ltd.
2023-11-08
$0.00/100g
Hefei Huana Biomedical Technology Co.,Ltd.
2023-03-29
$100.00/15kg
SHANGHAI NOVRIBO BIOTECH
2023-03-21
  • Since: 2004-10-27
  • Address: No. 11 Chengen Road, Pubagang Town, Sanmen County, Zhejiang Province
INQUIRY